Publication | Open Access
T Lymphocyte Activation Markers as Predictors of Responsiveness to Rituximab among Patients with FSGS
36
Citations
40
References
2016
Year
We have identified prognostic markers that define a subset of patients with FSGS bearing an immunologic signature representing hyporesponsiveness to T cell stimulation and therefore, who respond better to rituximab.
| Year | Citations | |
|---|---|---|
Page 1
Page 1